CAS RN 122320-73-4
CAS RN 122320-73-4
Rosiglitazone, TRC
CAS: 122320-73-4 Molecular Formula: C18 H19 N3 O3 S Molecular Weight (g/mol): 357.43 Synonym: 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-,5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,5-[[4-[2-[N-Methyl-N-(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione,BRL 49653,Rezult,Rosiglitazone,Rosiglizole,Rosvel,TDZ 01 IUPAC Name: 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione SMILES: O=C1SC(C(=O)N1)CC2=CC=C(OCCN(C3=NC=CC=C3)C)C=C2
Tocris Bioscience™ Rosiglitazone
Potent and selective PPARγ agonist; antidiabetic agent
Rosiglitazone, MedChemExpress
MedChemExpress Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer.